We apply innovative engineering approaches that leverage the natural virology of Papillomaviruses, creating platform delivery medicines that possess unique mechanisms of action. 

CORE TECHNOLOGY

Papillomavirus Virus-like Particles and their derivatives can act as broad platforms which can be utilized and applied in many ways. They have been demonstrated to be safe in humans and are highly immunogenic.

Scientific Publications

.